Over the past decade, immunotherapy has led to considerable progress in the treatment of certain cancers, including melanoma and lung cancer. But, for some reason, when faced with various types of tumors, some people respond better than others to this revolutionary treatment. In the midst of a search for a lever that can restore immunotherapy to its ability to wake up the immune system against cancer cells, epidrugs occupy a prominent place that is confirmed by results presented by a French team at the major international cancer congress in Chicago, Asco.
While genetic material (genes carried by DNA) can be considered as the instruction manual for the functioning of the organism, epigenetics can be likened to a switch capable of altering or inhibiting the expression of certain genes. Thus, epigenetic drugs aim to correct orders given when they hinder a cellular reaction...
This article is for subscribers only. You still have 80% to discover.
Want to read more?
Unblock all items immediately.
TEST FOR 0,99€
Already a subscriber? Log